Orthofix International | OFIX - Ordinary Share Capital


Orthofix International reported $39.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Accuray USD 100K 1000 Sep/2024
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 50.64M 7K Jun/2026
Dexcom USD 377.4M 8.5M Jun/2026
EDAP TMS EUR 37.48M 90K Mar/2026
Globus Medical USD 132.66M 1.59M Sep/2026
Inogen USD 23K 0 Dec/2023
Insulet USD 69.37M 16K Sep/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
J&J USD 2.41B 1.64M Jun/2026
Medtronic USD 1.28B 130K Jun/2026
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Orthofix International USD 39.83M 315K Dec/2025
Plus Therapeutics USD 275K 138.4M Mar/2026
Smith & Nephew USD 875.95M 11.64K Jun/2026
STAAR Surgical USD 50.2M 78K Sep/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 69.76M 217K Sep/2026
Teleflex USD 42.37M 1.89M Jun/2026
Veracyte USD 80.39M 598K Sep/2026
Zimmer Biomet Holdings USD 190.1M 3.3M Sep/2026